Jumbo Bag Ltd manufactures and exports large-scale flexible bulk containers (FIBCs) used for industrial transport and acts as a distribution agent for polymer raw materials.
The company operates in a highly fragmented, commodity-like industry with low barriers to entry and high labor intensity. While they hold some certifications and value-added patents, the thin net margins (1.1%) and low average ROCE (8.3%) indicate a lack of durable pricing power or structural cost advantages.
Management has prioritized debt reduction and operational stability following a major fire in 2013. Recent capital has been directed toward a solar power project to reduce energy costs and the acquisition of a small conversion unit's assets, though overall returns on equity remain very low.
Five years out, the business succumbed to a classic commodity trap where rising labor and raw material costs permanently outpaced the company's stagnant 1.1% net margins. The solar project failed to provide a sufficient cost buffer against global competitors with better scale, while the unresolved tax disputes and the loss of the Unit-2 leasehold premises forced a liquidity crunch. With no pricing power to pass on inflationary pressures, the thin returns on capital evaporated entirely, leaving the company as a 'zombie' enterprise that destroyed shareholder value through sheer operational mediocrity.
RichFakir rates Jumbo Bag Ltd's business quality as mediocre — 40/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Jumbo Bag Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Jumbo Bag Ltd is: Not rated. A mediocre business at an expensive price — it does not make our shortlist right now.
RichFakir's educational estimate of Jumbo Bag Ltd's fair value is about ₹30 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →